, a program of the Jonas Salk Legacy Foundation and Spencer Trask completed its first Innovation Challenge to identify novel solutions for IPV polio vaccine delivery.  Michael Docherty of Venture2 has been one of the primary leaders, along with Dr. Peter Salk (JSLF) and Kevin Kimberlin (ST&Co) in forming and launching this non-profit open innovation effort.